SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives rally is being driven by renewed enthusiasm around its real-world-asset and institutional-finance strategy, including tokenized mortgages, SEC transfer-agent registration, mainnet upgrades, native USDC, and deflationary buybacks. Traders are broadly bullish on the ecosystems growth and supply dynamics, though some remain cautious about pullbacks, short-term speculation, and the tokens prolonged downtrend.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Blocks quarterly earnings beat and raised full-year guidance are driving attention, but shares sold off as traders focused on a softer near-term outlook, modest user growth and rising credit exposure. The community is split between bulls citing Cash App/Square momentum, buybacks and analyst upgrades, and frustrated holders who view the stocks long-running range-bound performance as evidence of weak execution.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Rising crude and refined-fuel prices linked to Middle East and Strait of Hormuz tensions are driving heavy selling in Carnival and other cruise stocks, with traders focused on pressure on fuel costs and upcoming earnings. The community is split between bearish views that elevated oil and macro risks could push shares lower and bullish arguments that the stock is oversold, undervalued, and being heavily shorted despite resilient bookings and debt reduction.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

The final IPO lockup expiration and insider share sales are being blamed for persistent selling pressure despite Figmas strong quarter and raised outlook. Traders remain divided between optimism over AI-feature monetization and SaaS recovery versus concerns about added share supply, insider selling, and AI disruption.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Fed rate-hike risk, rising Treasury yields, and elevated oil prices are driving attention to VOO as traders assess pressure on broad U.S. equities. The community is split between bearish calls for a correction and moving to cash, and long-term investors viewing weakness as a buying opportunity for diversified index exposure.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduros MOU with AstroTurf to evaluate synthetic-turf recycling, alongside progress on its paraffinic-crude and first-of-a-kind facility programs, is driving attention. Bullish traders view the partnerships and technical milestones as validation of Hydrochemolytic Technology, while skeptics continue to question commercial economics, scalability, and dilution risk.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

Hunter Bidens $LAPTOP.X memecoin is drawing attention after a highly volatile launch followed by a rapid collapse, with traders widely describing it as a rug pull amid thin liquidity. Some speculative buyers are still calling for a rebound or squeeze, while most discussion focuses on losses, alleged insider benefits, and the tokens lack of clear utility.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp AVAX rebound and attempts to reclaim key technical levels are driving attention, with traders split between an early bull-market breakout and another short-lived pump. Bullish participants cite institutional tokenization and ecosystem adoption, while skeptics point to weak volume, persistent selling pressure, token inflation, and limited fee revenue.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation of topline results from Helus Pharmas late-stage APPROACH Phase 3 trial for HLP003 is driving attention, reinforced by new bullish analyst coverage. Traders remain divided between optimism over the psychedelic depression program and insider buying versus concerns about the binary clinical outcome, dilution, profit-taking, and options-related volatility.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Attention is centered on positive 52-week COMP360 Phase 3 data showing durable benefit in treatment-resistant depression, alongside expectations for a rolling NDA submission and potential FDA review. Traders are largely bullish on Compasss first-mover position and upcoming regulatory catalysts, though some remain concerned about commercialization costs, dosing logistics, and whether efficacy will materially exceed existing treatments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
